PAGE 9 — SYSTEM FAILURES

System Failures: The Institutions That Did Not See Her

This page analyses the structural failures of each relevant institution. It is addressed primarily to policymakers, journalists, and legal professionals. The failures described are systemic — they reflect the design of systems, not the failings of individuals working within them.

9.1 DVA and Defence: The Veteran as the Only Subject

The entire architecture of Australian veterans' welfare — the DVA claims system, the Statement of Principles framework, the medical support infrastructure, the non-liability healthcare program — is built around the veteran as the subject of harm and the subject of entitlement. The spouse exists in this system, if at all, as a carer, a support person, or a person with derivative claims arising from the veteran's death.

There is no mechanism within the DVA framework by which a spouse can make a claim for harm caused to her by a veteran's drug-induced neurological injury. There is no category of secondary casualty. There is no SOP for acquired domestic harm. There is no entitlement structure for the partner of a quinoline-affected veteran who has herself sustained physical, neurological, financial, or social injury as a direct consequence of a drug trial conducted on her partner.

The QVFA submission documents the systematic denial of appropriate care to veterans themselves — characterised as unlawful given the Commonwealth's duty of care to clinical trial subjects. The situation of the spouse is further removed still from any institutional acknowledgement. She is, in the strictest technical sense, invisible to the system.

9.2 The Repatriation Medical Authority and the ABI Gap

In 2017, the Repatriation Medical Authority (RMA) determined that there was insufficient evidence of a causal link between quinoline exposure and acquired brain injury. This determination was reached without examining any veterans' medical records and without expertise in clinical neurotoxicology.

The downstream consequences of this determination have been significant. Because acquired brain injury cannot be established as a DVA-compensable condition linked to quinoline exposure, the treatment framework available to affected veterans is calibrated — by the system's own logic — to psychiatric conditions rather than neurological ones. Wrong treatment for the veteran means wrong support for the family.

The perverse outcome is that veterans can access DVA support only through misdiagnosis as a psychiatric patient. This misalignment propagates outward: from the clinical record into the family court, into the domestic violence service system, and into the partner's own understanding of what is happening in her household.

The Royal Commission's 2024 recommendations have begun to shift this landscape. But the SOP gap for ABI has not yet been resolved, and the RMA determination has not been revisited through a process that meets the standard of neurotoxicological expertise the subject requires.

9.3 Domestic Violence Services: The Neurotoxicity Gap

Domestic violence services in Australia operate within well-developed frameworks calibrated to identify and respond to coercive control, cycles of abuse, and perpetrator accountability. These frameworks are appropriate and evidence-based for the large majority of domestic violence presentations.

They are not calibrated to recognise acquired brain injury as a contributing context. They have received no guidance or training specific to quinoline toxicity.

A partner presenting to a domestic violence service with experiences consistent with quinoline-related harm will receive support designed for a different causal context. The service will focus appropriately on safety planning, perpetrator programs, and legal remedies. It will not recognise that the veteran's behaviour may reflect a pharmacological brain injury that requires neurological — not psychological — intervention. It will not be able to offer the partner any framework for understanding what has happened to her partner's brain, or any pathway to a system capable of addressing that neurological reality.

This is not a criticism of domestic violence services. They respond with the information they have. The failure is systemic: the absence of any institutional framework connecting quinoline toxicity to domestic harm means that these services cannot respond appropriately regardless of their skill and commitment.

9.4 The Family Law System: Harm Framed as Relationship Conflict

Family court proceedings involving quinoline-affected veterans encounter the consequences of neurological injury without any framework for understanding its origin. The veteran's behaviour may be characterised as PTSD-related, as stress-related, or simply as the product of a relationship in difficulty. The pharmacological and neurological context is not captured by any existing legal category and is actively obscured by the veteran's misdiagnosis.

Courts assessing parenting capacity and contact arrangements are therefore working with an incomplete picture. They see periodic presentations of apparently normal functioning, a military service record, and engagement with treatment. They do not see that the treatment is calibrated to the wrong condition, that the neurological injury is unaddressed, and that the partner's concerns about safety are grounded in a specific neurobiological reality that the court has no framework to evaluate.

Partners attempting to raise quinoline-related risk in family court proceedings find that there is no clinical category to invoke, no DVA acknowledgement to cite, and no forensic precedent to which their legal representative can point. Their concerns are addressed — if at all — within the generic frameworks of PTSD and relationship conflict, which are inadequate to the specific harm they describe.

9.5 The Criminal Law System: Forensic Expertise That Does Not Yet Exist

In criminal proceedings where a veteran has committed serious violence, the forensic psychiatric assessment required to adequately evaluate the contribution of quinoline toxicity demands expertise that almost no Australian forensic psychiatrist currently possesses.

The forensic psychiatric literature addressing mefloquine as a potential partial defence or mitigating factor — developed by Ritchie, Block, and Nevin and published in the Journal of the American Academy of Psychiatry and the Law in 2013 — has not been incorporated into Australian legal practice or judicial education.

The consequence operates in two directions simultaneously. Partners who have been seriously harmed may find the legal system responding to their experience as ordinary relationship breakdown, without any recognition of the specific pharmacological context. Veterans who have caused serious harm may be convicted without any adequate assessment of the neurological factors contributing to their behaviour. Neither outcome serves justice.

9.6 The Absence of a Recognising Category

Perhaps the most fundamental institutional failure is conceptual: there is no category — in medicine, in law, in welfare policy, in domestic violence service provision — for the spouse harmed by service-related neurological injury.

Without a category, there is no recognition. Without recognition, there is no entitlement. Without entitlement, there is no support. Without support, the harm continues, accumulates, and compounds across a lifetime.

The spouse of an ADF quinoline veteran who has sustained harm as a consequence of her partner's drug trial is not quite a domestic violence victim in the ordinary sense — though she is that. She is not a carer in the ordinary sense — though she may be that. She is not a member of the ADF — though her life has been shaped by ADF decisions. She exists in the gaps between every category that might otherwise assist her.

Closing those gaps is not a matter of administrative adjustment. It requires deliberate policy, legislative action, and a fundamental reorientation of the veterans' welfare system to acknowledge that the consequences of military service extend beyond the person who served.